might prompt the unknowing to mortgage the house to buy a giant holding in AVXLs.
Not sure about AVXL, but @ recent interest rates and Market performance, I would think many more than have SHOULD manage their finances similarly. 2.49% + inflation (even after taxes) has been easily attained by all but the inept.
Falconer great points! If this were a Dr. speaking about a drug in Biogen or Lilly’s portfolio they would be fooly recognized by the market justifying a 20 billion dollar, or more, MC boost. Its only because its Anavex and their management that they are having to further support their data in Ph 3’s before the market and or world becomes “aware”.
Much better than what we get from the horse's ass.
So, all of the usual and expected cautions regarding this questionable information from Dr. Hagerman are certainly invited. My postings can be understood to be questionable. I have only undergraduate degrees in biology. But, Dr. Hagerman...? What could she accurately know about Anavex 2-73? Has she ever seen the drug in action in individuals with severe CNS diseases? She has.